产品说明
一般描述
PHAD®-504 was designed as a synthetic structural analog of detoxified monophosphoryl lipid A (MPLA) derived from E. coli lipopolysaccharide (LPS). It is structurally similar to PHAD®, differing only in the length of a single fatty acid chain. As expected, the activity of PHAD®-504 is quite similar to that of PHAD®, making the two products interchangeable as adjuvants in vaccine or immunotherapy formulations.
包装
2 mL Amber Glass Crimp Cap Vial (699810P-1mg)
2 mL Amber Glass Crimp Cap Vial (699810P-5mg)
其他说明
For R&D use only. Not for drug, household, or other uses.
法律信息
PHAD is a registered trademark of Avanti Polar Lipids, Inc.
基本信息
| 经验(实验)分子式 | C94H180 N3O22P |
| 分子量 | 1735.42 |
| NACRES | NA.25 |
产品性质
| 测定 | >99% (HPLC) |
| 形式 | powder |
| 包装 | pkg of 1 × 1 mg (699810P-1mg) pkg of 1 × 5 mg (699810P-5mg) |
| manufacturer/tradename | Avanti Polar Lipids 699810P |
| 运输 | dry ice |
| 储存温度 | −20℃ |
安全信息
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | No data available |
| 闪点(C) | No data available |
m.cnreagent.com
